HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Nakajima Selected Research

superoxide dismutase-poly(styrene co-maleic acid butyl ester)

5/2000Granulocyte-colony stimulating factor enhances anti-tumour effect of hyperthermia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Nakajima Research Topics

Disease

32Neoplasms (Cancer)
01/2014 - 03/2000
13Periodontitis
03/2013 - 02/2000
11Inflammation (Inflammations)
10/2018 - 03/2000
8Infections
02/2014 - 01/2001
7Lymphatic Metastasis
01/2009 - 09/2000
7Neoplasm Metastasis (Metastasis)
12/2007 - 05/2000
7Asthma (Bronchial Asthma)
08/2004 - 01/2000
6Stomach Neoplasms (Stomach Cancer)
09/2015 - 09/2000
6Carcinoma (Carcinomatosis)
01/2008 - 01/2000
6Carcinogenesis
11/2001 - 01/2000
4Periodontal Diseases (Periodontal Disease)
10/2018 - 08/2000
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2014 - 02/2008
4Atherosclerosis
06/2012 - 04/2000
4Body Weight (Weight, Body)
10/2011 - 10/2003
4Necrosis
04/2009 - 03/2000
4Gingivitis
12/2008 - 07/2005
4Osteoporosis
09/2002 - 01/2000
4Esophageal Neoplasms (Esophageal Cancer)
06/2001 - 01/2000
3Rheumatoid Arthritis
03/2020 - 03/2000
3Diabetes Mellitus
05/2014 - 09/2001
3Tuberculosis (Tuberculoses)
01/2011 - 01/2010
3Chronic Periodontitis
02/2010 - 03/2004
3Colorectal Neoplasms (Colorectal Cancer)
02/2010 - 11/2001
3Polyps
12/2003 - 12/2001
3Adenoma (Adenomas)
10/2001 - 07/2000
2Prostatic Neoplasms (Prostate Cancer)
07/2017 - 02/2009
2Disease Progression
09/2015 - 01/2014
2Bone Resorption
08/2015 - 01/2000
2Extensively Drug-Resistant Tuberculosis
01/2011 - 01/2010
2Coronary Disease (Coronary Heart Disease)
02/2010 - 03/2004
2Cicatrix (Scar)
02/2010 - 08/2009
2Aortic Dissection
11/2009 - 09/2003
2Autoimmune Diseases (Autoimmune Disease)
08/2008 - 06/2000
2Residual Neoplasm
01/2008 - 01/2000
2Osteosarcoma (Osteogenic Sarcoma)
10/2006 - 06/2001
2Hepatocellular Carcinoma (Hepatoma)
06/2006 - 02/2001
2Cataract (Cataracts)
05/2006 - 10/2003
2Dementia (Dementias)
04/2005 - 11/2002
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2004 - 03/2001
2Colonic Neoplasms (Colon Cancer)
03/2004 - 11/2001

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
01/2009 - 01/2000
8AntigensIBA
06/2004 - 02/2000
6CytokinesIBA
08/2015 - 01/2000
6Interleukin-4 (Interleukin 4)IBA
02/2014 - 02/2000
6Messenger RNA (mRNA)IBA
02/2009 - 02/2000
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2010 - 01/2000
4Biomarkers (Surrogate Marker)IBA
01/2014 - 07/2001
4Biological ProductsIBA
03/2013 - 05/2000
4DNA (Deoxyribonucleic Acid)IBA
01/2010 - 05/2001
4AllergensIBA
12/2001 - 08/2000
3InterferonsIBA
05/2014 - 08/2008
3Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2011 - 06/2004
3Pharmaceutical PreparationsIBA
01/2011 - 01/2001
3Cisplatin (Platino)FDA LinkGeneric
06/2010 - 01/2001
3Interleukin-6 (Interleukin 6)IBA
02/2010 - 01/2001
3LigandsIBA
01/2008 - 08/2000
3Interleukin-10 (Interleukin 10)IBA
07/2005 - 02/2000
3SteroidsIBA
08/2004 - 04/2001
3Adrenal Cortex Hormones (Corticosteroids)IBA
08/2004 - 04/2000
3Immunoglobulin E (IgE)IBA
08/2004 - 12/2001
3beta CateninIBA
11/2002 - 11/2000
3HDL LipoproteinsIBA
12/2001 - 03/2000
3Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2001 - 02/2000
3Tumor Suppressor Protein p14ARF (p14ARF)IBA
03/2001 - 09/2000
3ChemokinesIBA
03/2001 - 01/2000
2OsteopontinIBA
03/2019 - 01/2000
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
10/2018 - 02/2009
2S-1 plus cisplatinIBA
09/2015 - 06/2010
2Irinotecan (Camptosar)FDA LinkGeneric
09/2015 - 02/2010
2Immunoglobulin G (IgG)IBA
02/2014 - 10/2010
2Polysaccharides (Glycans)IBA
03/2013 - 08/2000
2Blood Proteins (Serum Proteins)IBA
06/2012 - 09/2001
2Liposomes (Liposome)IBA
01/2011 - 01/2010
2VaccinesIBA
01/2011 - 01/2010
2DNA VaccinesIBA
01/2011 - 01/2010
2Interleukin-12 (IL 12)IBA
01/2011 - 01/2010
2Reactive Oxygen Species (Oxygen Radicals)IBA
02/2010 - 05/2000
2Interleukin-8 (Interleukin 8)IBA
04/2009 - 01/2000
2Interleukin-5 (Interleukin 5)IBA
04/2009 - 08/2004
2Cadherins (E-Cadherin)IBA
03/2009 - 10/2008
2TegafurIBA
12/2007 - 03/2004
2UracilIBA
12/2007 - 03/2004
2Triglycerides (Triacylglycerol)IBA
11/2006 - 01/2000
2Selenious Acid (Selenite)IBA
05/2006 - 10/2003
2Protein Isoforms (Isoforms)IBA
02/2006 - 01/2001
2AntibodiesIBA
02/2006 - 03/2004
2Interleukin-13IBA
08/2004 - 03/2000
2Chaperonin 60IBA
06/2004 - 03/2004
2Fluorouracil (Carac)FDA LinkGeneric
03/2004 - 10/2000
2Codon (Codons)IBA
11/2002 - 11/2000
2Glucose (Dextrose)FDA LinkGeneric
03/2002 - 08/2000

Therapy/Procedure

13Therapeutics
09/2015 - 01/2000
9Drug Therapy (Chemotherapy)
09/2015 - 05/2000
4Radiotherapy
04/2001 - 01/2000
3Gastrectomy
06/2010 - 10/2000
3Operative Surgical Procedures
02/2010 - 05/2000
2Subcutaneous Injections
07/2017 - 10/2003
2Lymph Node Excision (Lymph Node Dissection)
01/2008 - 01/2001
2Adjuvant Chemotherapy
12/2007 - 10/2000
2Oral Administration
06/2006 - 12/2001